Net Income - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98%
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Net Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Net Income
-$37.9m
CAGR 3-Years
-47%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Net Income
$6.2B
CAGR 3-Years
-10%
CAGR 5-Years
12%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Net Income
$4.2B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
5%
Mettler-Toledo International Inc
NYSE:MTD
Net Income
$785.7m
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
10%
Agilent Technologies Inc
NYSE:A
Net Income
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
7%
IQVIA Holdings Inc
NYSE:IQV
Net Income
$1.4B
CAGR 3-Years
31%
CAGR 5-Years
38%
CAGR 10-Years
16%

See Also

What is MaxCyte Inc's Net Income?
Net Income
-37.9m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Net Income amounts to -37.9m USD.

What is MaxCyte Inc's Net Income growth rate?
Net Income CAGR 5Y
-34%

Over the last year, the Net Income growth was -61%. The average annual Net Income growth rates for MaxCyte Inc have been -47% over the past three years , -34% over the past five years .

Back to Top